BRIEF-Vanda Pharmaceutical announced results from study of Tradipitant as a treatment of chronic pruritus
September 13, 2017 at 16:23 PM EDT
* Vanda Pharmaceuticals Inc - announced results from randomized phase ii clinical study of Tradipitant as a monotherapy in treatment of chronic pruritus